We found for Filter results by Theme Select the product option you would like to filter Theme Economics of Innovation Measuring and Valuing Outcomes Policy, Organisation and Incentives in Health Systems Value, Affordability, and Decision Making Topic Select the product option you would like to filter Topic Antimicrobial Resistance (AMR) Biosimilars Cell and Gene Therapies Chronic Diseases Combination Therapies COVID-19 Research Dementia Digital Health Drug Development/R&D Emerging Markets EQ-5D and PROMs Health Care Systems Health Data and Statistics Health Technology Assessment (HTA) Indication-Based Pricing Innovation Policy Prize OHE Consulting Precision Medicine Prevention Real World Evidence (RWE) Research Sustainability Use of Medicines Vaccines Value-Based Pricing Tag Select the product option you would like to filter Tag Adult Immunisation Alzheimer's Broader value and societal perspective in HTA Budget Impact Analysis Cancer Cardiovascular Disorders Care-givers Caring burden Cervical Cancer Clinical Outcomes Commentary Competition Dermatology Determining Value Diversity of Supply Drug Shortages Economic Evaluation Egypt Epidemiology and Public Health Epilepsy Gene therapies Generics Greece Haemophilia Health Policy and Regulation Health System Resiliency Healthcare Delivery Healthcare Expenditure Healthcare Funding Healthcare System Pressure (HCSP) India Infectious Diseases Inflation Reduction Act Injury and Trauma Innovation Israel Market Access Mental Health Pharmaceutical Industry Plant-based Policy Analysis Pricing and Reimbursement Primary Care Quality of Care Quality of Life Rare and Orphan Diseases Research Funding Resource Allocation Respiratory Cost Calculator Saudi Arabia Slovak Republic Societal preferences Supply of Medicine Türkiye Unmet Need Vaccines Value based pricing Webinar Date 1 Select the product option you would like to filter Date Clear Filter Date From Month From Year From Date To Month To Year To January February March April May June July August September October November December total + el.scrollHeight*2, 0) + 'px'" > Today - 2020 2020 2021 2022 2023 2024 2025 2019 - 2010 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2009 - 2000 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 1999 - 1990 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 1989 - 1980 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1979 - 1970 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1969 - 1960 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 January February March April May June July August September October November December total + el.scrollHeight*2, 0) + 'px'" > Today - 2020 2020 2021 2022 2023 2024 2025 2019 - 2010 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2009 - 2000 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 1999 - 1990 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 1989 - 1980 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1979 - 1970 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1969 - 1960 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 Author Select the product option you would like to filter Author Search authors Edwine Barasa Angela Kairu Neil Mcauslane Adam Raymakers Kiran Bhatti Kelsey Moore Meindert Boysen Pedro Pita Barros Andrew Briggs Thomas Pogge Content Type Select the product option you would like to filter Content Type news story insight events podcast bulletin publications Reset Filters Chronic Diseases Value, Affordability, and… Understanding the Full Value of Long-Acting Therapies: less is more? Read more Health Technology Assessment… Value, Affordability, and… An Analysis of NICE’s Optimised Decisions from 2015 to 2024 Read more Health Technology Assessment… Value, Affordability, and… Broader value and societal… The BRAVER Roadmap to Broader Assessment of the Value of Health Interventions in the Asia-Pacific Region Read more Insight April 2025 Adding a “Cognition Bolt-on” to EQ-5D-5L: Insights from New Research and What’s Next Read more Insight April 2025 Around the World in HTAs: Canada – Autonomous yet Collaborative Read more Cell and Gene Therapies Value, Affordability, and… Budget Impact Analysis Challenges and Solutions for Budget Impact Analysis of Gene Therapies Read more Insight December 2024 OHE’s submission for the DHSC’s next 10 years of planning Read more Health Technology Assessment… Measuring and Valuing Outcomes Societal preferences Understanding societal preferences for priority by disease severity in England & Wales Read more Insight November 2024 Is collaboration between and across regulatory and HTA agencies the answer to access challenges? Read more Insight September 2024 Around The World in HTAs: Thailand – An Ever-Evolving Policy Tool Read more Combination Therapies Value, Affordability, and… Unlocking the Value of Combination Therapies Read more ©Tombaky - stock.adobe.com Insight June 2024 Around the World in HTAs: United States – Making HTA Great Again Read more Health Technology Assessment… Value, Affordability, and… How Have HTA Agencies Evolved Their Methods Over Time? Read more Health Care Systems Value, Affordability, and… Socio-Economic Value of Adult Immunisation Programmes Read more © Photo And Art Panda on stock.adobe.com Insight April 2024 Kahneman’s legacy in health economics Read more Past Event OHE Webinar March 2024 The Future of NICE in a Changing HTA Landscape Read more Load More
Chronic Diseases Value, Affordability, and… Understanding the Full Value of Long-Acting Therapies: less is more? Read more
Health Technology Assessment… Value, Affordability, and… An Analysis of NICE’s Optimised Decisions from 2015 to 2024 Read more
Health Technology Assessment… Value, Affordability, and… Broader value and societal… The BRAVER Roadmap to Broader Assessment of the Value of Health Interventions in the Asia-Pacific Region Read more
Insight April 2025 Adding a “Cognition Bolt-on” to EQ-5D-5L: Insights from New Research and What’s Next Read more
Cell and Gene Therapies Value, Affordability, and… Budget Impact Analysis Challenges and Solutions for Budget Impact Analysis of Gene Therapies Read more
Health Technology Assessment… Measuring and Valuing Outcomes Societal preferences Understanding societal preferences for priority by disease severity in England & Wales Read more
Insight November 2024 Is collaboration between and across regulatory and HTA agencies the answer to access challenges? Read more
Combination Therapies Value, Affordability, and… Unlocking the Value of Combination Therapies Read more ©Tombaky - stock.adobe.com
Health Technology Assessment… Value, Affordability, and… How Have HTA Agencies Evolved Their Methods Over Time? Read more
Health Care Systems Value, Affordability, and… Socio-Economic Value of Adult Immunisation Programmes Read more © Photo And Art Panda on stock.adobe.com